AI BEAVERS

the dam brief #5

rise and chew, beavers. this week: OpenAI tops up its fundraising round to $120B+ at an $850B valuation, Claude Code ships autonomous permission handling, and an organ-on-a-chip study finds oxytocin outperforms rapamycin as a rejuvenation agent.